Inventor

MURRAY WILLIAM V

US46 patents

⚠️ This page may combine multiple inventors who share the name “MURRAY WILLIAM V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MURRAY WILLIAM V

ORTHO PHARMA CORP

Pharmacologically active 2- and 3-substituted (1&#39;,5&#39;-diaryl-3-pyrazolyl)-N-hydroxypropanamides

Cinnamohydroxamic acids

Pharmacologically active N-1 and C-5 heterocyclic pyrazoles and method for synthesizing the same

Substituted n-biphenylyl lactams

Angiotensin II inhibitors

N-hydroxy, N-methyl propanamides

Regioselective synthesis of a 1,5-disubstituted pyrazole

Hydroxamic acids and esters

Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Substituted triazoles as angiotensin II inhibitors

Regioselective synthesis of 1,5-diaryl pyrazole anti-inflammatory agents

Substituted triazoles as angiotensin II inhibitors

2-oxo tetrahydrofuran compounds

Substituted n-biphenylyl lactams

Substituted triazoles as angiotensin ii inhibitors

Amido substituted naphthalenes and intermediates thereof

Heterocyclic intermediates

ORTHO MCNEIL PHARM INC

Substituted amino acids as erythropoietin mimetics

Substituted amino acids as erythropoietin mimetics

Heterocycles useful in the treatment of benign prostatic hyperplasia

Macroheterocylic compounds useful as kinase inhibitors

Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries

Methods for the synthesis of complex reduced isoindole, isooxyindole and isooxyquinoline libraries

Methods for the synthesis of densely functionalized pyrrolidine intermediates

Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries

Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia

Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia

Substituted amino acids as erythropoietin mimetics

Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia

BASF AG

Diaryl-substituted heterocyclic compounds, drugs and cosmetics obtained therefrom

Diaryl-substituted heterocyclic compounds, drugs and cosmetics obtained therefrom

Diaryl-substituted heterocyclic compounds, their preparation and drigs and cosmetics obtained therefrom

Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom

Phenylhydrazones, the manufacture thereof and therapeutic and cosmetic compositions prepared therefrom

Diaryl-substituted pyrazole compounds and drugs and cosmetics obtained therefrom

JOHNSON & JOHNSON BABY PROD

Sunscreen compositions

Sunscreen compositions

Sunscreen compositions containing vinylogous amides

Sunscreen compositions

Sunscreen compositions

JANSSEN PHARMACEUTICA NV

Cyclohexyl derivatives as selective estrogen receptor modulators

Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse agonists

JOHNSON & JOHNSON PHARM RES

Non-peptidic NPY Y2 receptor inhibitors

ORTH MCNEIL PHARMACEUTICAL INC

Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

CONNOLLY PETER J

Substituted amino acids as erythropoietin mimetics

JANSEEN PHARMACEUTICA N V

Heterocycles useful in the treatment of benign prostatic hyperplasia

Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-N-hydroxypropanamides